190 related articles for article (PubMed ID: 29285838)
1. Vasomotor, urogenital, psychological, and somatic symptoms in association with CYP1B1 polymorphisms in Slovak women of different menopausal status.
Candráková Čerňanová V; Danková Z; Vorobeľová L; Cvíčelová M; Siváková D
Am J Hum Biol; 2018 May; 30(3):e23094. PubMed ID: 29285838
[TBL] [Abstract][Full Text] [Related]
2. Menopausal complaints in Slovak midlife women and the impact of CYP1B1 polymorphism on their incidence.
Luptáková L; Sivtáková D; Cernanová V; Cvicelová M
Anthropol Anz; 2012; 69(4):399-415. PubMed ID: 23350153
[TBL] [Abstract][Full Text] [Related]
3. The association of Asn453Ser polymorphism in CYP1B1 gene with selected somatic and biochemical variables in Slovak women of different menopause status.
Čerňanová V; Danková Z; Luptáková L; Cvíčelová M; Siváková D
Menopause; 2016 May; 23(5):577-83. PubMed ID: 26757271
[TBL] [Abstract][Full Text] [Related]
4. The association of cytochrome P450 1B1 Leu432Val polymorphism with biological markers of health and menopausal symptoms in Slovak midlife women.
Luptáková L; Sivaková D; Srámeková D; Cvíčelová M
Menopause; 2012 Feb; 19(2):216-24. PubMed ID: 22011756
[TBL] [Abstract][Full Text] [Related]
5. Association of cytochrome P450 1B1 gene polymorphisms and environmental biomarkers with hypertension in Slovak midlife women.
Falbová D; Vorobeľová L; Čerňanová VC; Beňuš R; Wsólová L; Siváková D
Menopause; 2020 Nov; 27(11):1287-1294. PubMed ID: 33110045
[TBL] [Abstract][Full Text] [Related]
6. Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis.
He XF; Wei J; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ; Liu Q; Wu LX; Wei W
PLoS One; 2014; 9(8):e100487. PubMed ID: 25115775
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the CYP1B1 gene may be associated with the onset of natural menopause in Chinese women.
Long JR; Shu XO; Cai Q; Cai H; Gao YT; Jin F; Zheng W
Maturitas; 2006 Oct; 55(3):238-46. PubMed ID: 16766147
[TBL] [Abstract][Full Text] [Related]
8. Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.
Liu JY; Yang Y; Liu ZZ; Xie JJ; Du YP; Wang W
Mol Genet Genomics; 2015 Apr; 290(2):739-65. PubMed ID: 25475389
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: observations from the Seattle Midlife Women's Health Study.
Woods NF; Mitchell ES; Tao Y; Viernes HM; Stapleton PL; Farin FM
Menopause; 2006; 13(6):902-10. PubMed ID: 16977255
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and severity of menopause symptoms among perimenopausal and postmenopausal women aged 30-49 years in Gulele sub-city of Addis Ababa, Ethiopia.
Yisma E; Eshetu N; Ly S; Dessalegn B
BMC Womens Health; 2017 Dec; 17(1):124. PubMed ID: 29216870
[TBL] [Abstract][Full Text] [Related]
11. Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis.
Xu W; Zhou Y; Hang X; Shen D
Mol Biol Rep; 2012 Mar; 39(3):2821-9. PubMed ID: 21674184
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.
Teng Y; He C; Zuo X; Li X
Int J Gynecol Cancer; 2013 Mar; 23(3):422-30. PubMed ID: 23370603
[TBL] [Abstract][Full Text] [Related]
13. Change in psychological and vasomotor symptom reporting during the menopause.
Hardy R; Kuh D
Soc Sci Med; 2002 Dec; 55(11):1975-88. PubMed ID: 12406465
[TBL] [Abstract][Full Text] [Related]
14. Associated factors with urogenital score in natural and surgical menopause.
Hassa H; Tanir HM; Yildirim A; Senses T; Oge T; Mutlu FS
Maturitas; 2005 Sep; 52(1):65-9. PubMed ID: 16143227
[TBL] [Abstract][Full Text] [Related]
15. Association between CYP1B1 gene polymorphisms and risk factors and susceptibility to laryngeal cancer.
Yu PJ; Chen WG; Feng QL; Chen W; Jiang MJ; Li ZQ
Med Sci Monit; 2015 Jan; 21():239-45. PubMed ID: 25619313
[TBL] [Abstract][Full Text] [Related]
16. Urogenital and vasomotor symptoms in relation to menopausal status and the use of hormone replacement therapy (HRT) in healthy women during transition to menopause.
Larson B; Collins A; Landgren BM
Maturitas; 1997 Dec; 28(2):99-105. PubMed ID: 9522318
[TBL] [Abstract][Full Text] [Related]
17. The menopausal transition was associated in a prospective study with decreased health functioning in women who report menopausal symptoms.
Kumari M; Stafford M; Marmot M
J Clin Epidemiol; 2005 Jul; 58(7):719-27. PubMed ID: 15939224
[TBL] [Abstract][Full Text] [Related]
18. Severity of menopausal symptoms of Jordanian women.
Gharaibeh M; Al-Obeisat S; Hattab J
Climacteric; 2010 Aug; 13(4):385-94. PubMed ID: 19731118
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors.
Grigoriou V; Augoulea A; Armeni E; Rizos D; Alexandrou A; Dendrinos S; Panoulis K; Lambrinoudaki I
Gynecol Endocrinol; 2013 Feb; 29(2):125-8. PubMed ID: 22849709
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer.
Singh AP; Shah PP; Mathur N; Buters JT; Pant MC; Parmar D
Mutat Res; 2008 Mar; 639(1-2):11-9. PubMed ID: 18067928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
